Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Mantle Cell Lymphoma

Breast Cancer

Gastrointestinal Cancer

Mantle Cell Lymphoma

Kahl Looks Toward the Future in MCL

Brad Kahl, MD, discusses the exciting new advancements on the horizon for the treatment of patients with mantle cell lymphoma.
Read More >>

Goy Discusses Maintenance, CAR T-Cell Therapy in MCL

Maintenance Rituximab Linked to Improved Outcomes in MCL

MCL Researcher Highlights Future of CAR T-Cell Therapy, Other Approaches

Expert Discusses Venetoclax Potential in MCL

CAR T-Cell Therapy Explored in Mantle Cell Lymphoma

View More Stories >>

View Conference Coverage

2018 International Lung Cancer Congress

2018 Pan Pacific Lymphoma Conference

2nd Annual Live Medical Crossfire® : Hematologic Malignancies

State of the Science Summit on A Summer of Progress: Updates from ASCO 2018

2018 State of the Science Summit on Breast Cancer

Challenges in the Treatment of Patients With MCL

$Dr. Eyre on Results of Venetoclax in Relapsed/Refractory MCL$

Dr. Eyre on Results of Venetoclax in Relapsed/Refractory MCL

Dr. Goy on the Combination of Biological Therapies in Relapsed MCL

Dr. Kahl on the Potential of CAR T-Cell Therapy in MCL

Dr. Goy on the Evolution of Treatment in Mantle Cell Lymphoma

Dr. Kahl Discusses the Potential of Frontline Ibrutinib in MCL

Dr. Hilal Discusses Study of Rituximab Maintenance in MCL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Highlights from ASH 2017: Mantle Cell Lymphoma

Investigational Treatment in Mantle Cell Lymphoma

Future Therapy: Bruton's TKI Containing Combinations in MCL

Allogeneic Transplantation in Mantle Cell Lymphoma

Acalabrutinib in Relapsed Mantle Cell Lymphoma

Ibrutinib in Relapsed Mantle Cell Lymphoma

Understanding Relapse in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

How to Properly Utilize MRD Testing

Emerging Agents for Mantle Cell Lymphoma

Acalabrutinib for Treating Mantle Cell Lymphoma

Ongoing Challenges in Treating Mantle Cell Lymphoma

$Treating Relapsed/Refractory Mantle Cell Lymphoma$

Role of Maintenance Therapy in Mantle Cell Lymphoma

Response Assessment in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Ibrutinib in Relapsed Mantle Cell Lymphoma

Drs Danilov, Goy, Leonard, Pagel, and Schuster, discuss ibrutinib (Imbruvica) as a treatment in relapsed mantle cell lymphoma. View Now

Treatments for Relapsed Mantle Cell Lymphoma

Brad S. Kahl, MD, and Richard R. Furman, MD, explain available treatment options for relapsed mantle cell lymphoma. View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval in CTCL, Breakthrough Therapy Designation in CRC, and More